Sarah Bos

Chapter 1 General introduction	9
Chapter 2 Hemostatic profiles are similar across all etiologies of cirrhosis.	19
Chapter 3 Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or to non-alcoholic fatty liver disease.	37
Chapter 4 Anticoagulant activity of edoxaban in patients with cirrhosis.	49
Chapter 5 Hemostatic complications in hepatobiliary surgery.	63
Chapter 6 The efficacy of pro- and anticoagulant therapy in plasma of patients undergoing hepatobiliary surgery.	87
Chapter 7 Discussion, and future perspectives	119
Nederlandse samenvatting	136
Lijst van publicaties	140
Curriculum vitae	141
Dankwoord	142

Made with FlippingBook

RkJQdWJsaXNoZXIy ODAyMDc0